✦ LIBER ✦

Everolimus-eluting vs. Bare Metal Stents in Octogenarians. Results from the Randomized XIMA (XIence or Vision Stent Management of Angina in the Elderly) Trial

✍ Scribed by De La Torre Hernandez, Jose Maria; De Belder, Adam; Palop, Ramon Lopez; Hildick-Smith, David; Hernandez, Felipe; O'Kane, Peter; Gimeno, Federico; Thomas, Martin; Diaz, Jose Francisco; Curzen, Nick; Saez, Pilar Carrillo; Strange, Julian; Pinar, Eduardo; Cotton, James; Baz, Jose Antonio; Adamson, Dawn; Lozano, Iñigo; Blackman, Daniel; Cuellas, Carlos; Skipper, Nicola; Cooter, Nina; Diarte, Jose Antonio; Smith, David; Mauri, Josepa

Book ID: 122429499
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 55 KB
Volume: 111
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2013.01.346

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EVEROLIMUS–ELUTING VERSUS BARE METAL STE

EVEROLIMUS–ELUTING VERSUS BARE METAL STENTS IN OCTOGENARIANS: RESULTS FROM THE RANDOMIZED XIMA (XIENCE OR VISION STENT – MANAGEMENT OF ANGINA IN THE ELDERLY) TRIAL

✍ de la Torre Hernandez, Jose M.; Belder, Adam De; Palop, Ramon Lopez; Hildick–Smi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 160 KB

A randomized comparison of drug-eluting

A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)

✍ Alfonso, Fernando (author);Pérez-Vizcayno, Maria Jose (author);Cárdenas, Alberto 📂 Article 📅 2014 🏛 Elsevier USA 🌐 English ⚖ 504 KB

Benefits of drug-eluting stents as compa

Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: Four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial

✍ Emilio Di Lorenzo; Rosario Sauro; Attilio Varricchio; Michele Capasso; Tonino La 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Outcomes in Diabetic and Nondiabetic Pat

Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents: Results From the SPIRIT IV Clinical Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)

✍ Dean J. Kereiakes; Donald E. Cutlip; Robert J. Applegate; John Wang; Manejeh Yaq 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 349 KB

TCT-384: Evaluation of Everolimus-Elutin

TCT-384: Evaluation of Everolimus-Eluting and Paclitaxel-Eluting Stents in Elderly Patients: 2-Year Results from the SPIRIT III Randomized Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Long-Term Clinical and Economic Analysis

Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)

✍ Eric L. Eisenstein; William Wijns; Jean Fajadet; Laura Mauri; Rex Edwards; Patri 📂 Article 📅 2009 🏛 American College of Cardiology 🌐 English ⚖ 364 KB